Page last updated: 2024-08-21

adamantane and Bilateral Headache

adamantane has been researched along with Bilateral Headache in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnett, AH; Charbonnel, B; Donovan, M; Fleming, D; Iqbal, N; Li, J	1
Borja-Hart, NL; Whalen, KL	1
Campestrini, J; Dole, K; Dole, WP; He, YL; Howard, D; Ligueros-Saylan, M; Marion, A; Pommier, F; Sabo, R; Sunkara, G; Wang, Y; Zhao, C	1

Reviews

1 review(s) available for adamantane and Bilateral Headache

Article	Year
Saxagliptin: a new dipeptidyl peptidase 4 inhibitor for type 2 diabetes. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:6 Topics: Adamantane; Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Headache; Humans; Respiratory Tract Infections	2010

Trials

2 trial(s) available for adamantane and Bilateral Headache

Article	Year
Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy. Clinical drug investigation, 2013, Volume: 33, Issue:10 Topics: Adamantane; Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Time Factors; Treatment Outcome; Urinary Tract Infections; Young Adult	2013
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects. Journal of clinical pharmacology, 2008, Volume: 48, Issue:1 Topics: Adamantane; Administration, Oral; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Half-Life; Headache; Humans; Male; Middle Aged; Nausea; Nitriles; Pyrrolidines; Ramipril; Tablets; Tetrazoles; Valine; Valsartan; Vildagliptin	2008

Article

Year

Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.

Clinical drug investigation, 2013, Volume: 33, Issue:10

Topics: Adamantane; Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Time Factors; Treatment Outcome; Urinary Tract Infections; Young Adult

2013

Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.

Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

Topics: Adamantane; Administration, Oral; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Half-Life; Headache; Humans; Male; Middle Aged; Nausea; Nitriles; Pyrrolidines; Ramipril; Tablets; Tetrazoles; Valine; Valsartan; Vildagliptin

2008